France· FR:67592737
TRINARA CONTINU, comprimé pelliculé
A medicinal product containing éthinylestradiol + norgestimate, registered in France by EXELTIS SANTE.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ÉTHINYLESTRADIOL + NORGESTIMATE
- Manufacturer
- EXELTIS SANTE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009302766933 plaquettes PVC polyéthylène PVDC aluminium de 28 comprimés
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Éthinylestradiol + norgestimate in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCilest 35microgram/250microgram tabletsJanssen-Cilag Ltd
- CanadaTRI-CIRA 21APOTEX INC
- PolandElinZakłady Farmaceutyczne POLPHARMA S.A.
- FinlandCilestJanssen-Cilag Oy
- SpainEDELSIN comprimidosJanssen-Cilag
- SwitzerlandLiberelle, FilmtablettenExeltis Suisse SA
- GermanyAmicetteAristo Pharma Gmbh (Art 57)
- NetherlandsNorgestimaat/Ethinylestradiol Xiromed 0,25 mg/0,035 mg tablettenMedical Valley Invest AB
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Belgium · Cibel
- Germany · Amicette, Lysandra
- Denmark · Amorina, Liberelle
- Spain · Edelsine
- United Kingdom (Northern Ireland) · Cilique, Lizinna
- Ireland · Cilique
- Italy · Briladona, Briladona Trifase
- Netherlands · Norgestimaat/Ethinylestradiol Xiromed
- Norway · Amorina
- Poland · Elin, Liberelle
- Portugal · Etinilestradiol + Norgestimato Leon Farma, Femi
- Sweden · Amorina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad0cb025-3fdf-4621-8c1f-bf7689276f28 GET /v1/drugs/ad0cb025-3fdf-4621-8c1f-bf7689276f28?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67592737",
"date_amm": "2023-07-12",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "ÉTHINYLESTRADIOL + NORGESTIMATE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé(s)",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about éthinylestradiol + norgestimate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.